Drugs / 62Cu-ETS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01502228 | Oct 2011 → Feb 2014 | renal cell carcinoma | Indiana University | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 62Cu-ETS | “Imaging with 62Cu-ETS will be done immediately following imaging with 150-water.” NCT01502228 ↗ |
| Route | Intravenous | “Administer 62Cu-ETS in the range of 20-25 mCi/Dose, IV.” NCT01502228 ↗ |